We are live on
!
Find out more
DCM
Discovery Capital Management Portfolio holdings
AUM
$1.92B
1-Year Est. Return
218.96%
This Fund
S&P 500
This Quarter
Est. Return
+13.26%
1 Year Est. Return
+218.96%
3 Year Est. Return
+556.4%
5 Year Est. Return
+606.07%
10 Year Est. Return
+5,733.18%
AUM
$8.44B
AUM Growth
-$553M
(-6.2%)
Cap. Flow
-$1.39B
Cap. Flow
% of AUM
-16.51%
Top 10 Holdings %
Top 10 Hldgs %
40.85%
Holding
146
New
35
Increased
17
Reduced
28
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$316M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$183M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$182M |
| 4 |
Pfizer
PFE
|
+$164M |
| 5 |
Morgan Stanley
MS
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$540M |
| 2 |
Apple
AAPL
|
+$246M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$231M |
| 4 |
Biogen
BIIB
|
+$204M |
| 5 |
Amazon
AMZN
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.44% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 11.95% |
| 4 | Communication Services | 10.61% |
| 5 | Technology | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alibaba
BABA
$276B
| $862M | 10.21% |
10,601,004
+4,032,400
| +61% | +$316M |
|
|
2
Pfizer
PFE
$144B
| $471M | 5.58% |
15,373,328
+5,209,184
| +51% | +$164M |
|
3
CALL
iShares China Large-Cap ETF
FXI
$4.27B
| $406M | 4.81% |
+11,500,000
| New | +$432M |
|
|
ENDP
4
DELISTED
Endo International plc
ENDP
| $337M | 3.99% |
5,504,830
+979,230
| +22% | +$59.5M |
|
|
SCHW
5
Charles Schwab
SCHW
$184B
| $298M | 3.53% |
9,040,384
+5,741,084
| +174% | +$182M |
|
|
6
CALL
Alibaba
BABA
$276B
| $272M | 3.23% |
3,350,000
-650,000
| -16% | -$51M |
|
7
McDonald's
MCD
$194B
| $211M | 2.5% |
1,783,850
+94,950
| +6% | +$10.6M |
|
8
NetEase
NTES
$81.5B
| $201M | 2.38% |
5,549,445
-4,893,955
| -47% | -$152M |
|
9
T-Mobile US
TMUS
$196B
| $196M | 2.33% |
5,018,146
-16,000
| -0.3% | -$618K |
|
|
10
Teva Pharmaceuticals
TEVA
$36.9B
| $194M | 2.3% |
+2,958,200
| New | +$183M |
|
|
CVC
11
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $181M | 2.15% |
5,676,984
-1,065,315
| -16% | -$33.7M |
|
12
CALL
State Street Financial Select Sector SPDR ETF
XLF
$57.4B
| $179M | 2.12% |
+8,543,595
| New | +$180M |
|
|
MDVN
13
DELISTED
MEDIVATION, INC.
MDVN
| $170M | 2.02% |
3,523,582
-249,018
| -7% | -$10.7M |
|
14
Baidu
BIDU
$35.6B
| $166M | 1.97% |
878,209
-637,150
| -42% | -$117M |
|
15
Yum! Brands
YUM
$41.4B
| $161M | 1.91% |
3,063,330
+1,326,041
| +76% | +$69.3M |
|
|
16
Amazon
AMZN
$2.48T
| $148M | 1.75% |
4,369,900
-6,069,060
| -58% | -$191M |
|
17
Dollar Tree
DLTR
$24.4B
| $146M | 1.74% |
1,896,888
-146,750
| -7% | -$10.3M |
|
18
AerCap
AER
$24.3B
| $145M | 1.72% |
3,367,394
-76,000
| -2% | -$3.18M |
|
|
19
Morgan Stanley
MS
$333B
| $137M | 1.62% |
+4,296,600
| New | +$143M |
|
|
QIHU
20
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $123M | 1.45% |
1,684,964
-390,500
| -19% | -$24.6M |
|
21
CALL
GE Aerospace
GE
$377B
| $117M | 1.38% |
+782,483
| New | +$111M |
|
22
Alphabet (Google) Class C
GOOG
$4.07T
| $116M | 1.38% |
3,069,840
-3,777,000
| -55% | -$136M |
|
|
S
23
DELISTED
Sprint Corporation
S
| $115M | 1.36% |
31,669,299
+5,070,643
| +19% | +$20.8M |
|
24
YPF
YPF
$19.5B
| $114M | 1.35% |
7,262,124
+2,114,592
| +41% | +$38.7M |
|
25
Bank of America
BAC
$439B
| $112M | 1.32% |
+6,637,000
| New | +$112M |
|
Similar funds
CC
RCAG
HC
QOP
6CM
HCL
RIL
AAA
Discovery Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Discovery Capital Management held 146 positions worth $8.44B, down 6.2% from $8.99B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Discovery Capital Management withdrew a net $1.39B in Q4 2015, closing 55 positions and reducing 28 holdings. Its most notable exit was Allergan plc, an estimated $540M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Discovery Capital Management opened a new position in Teva Pharmaceuticals worth $194M.
- Discovery Capital Management's largest Q4 2015 buy was Teva Pharmaceuticals: 2,958,200 shares worth $194M.
- Discovery Capital Management added most to Alibaba in Q4 2015, an estimated $316M increase.
- Discovery Capital Management's biggest Q4 2015 reduction was Amazon, cutting an estimated $191M.
- Discovery Capital Management fully exited Allergan plc in Q4 2015, selling an estimated $540M.
- Discovery Capital Management's ten largest holdings make up 41% of its $8.44B portfolio in Q4 2015.
- Discovery Capital Management opened 35 new positions and closed 55 in Q4 2015.
- Discovery Capital Management's portfolio value fell 6.2% quarter-over-quarter to $8.44B.
Based on Discovery Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.